So great news guys with the approval from ODAC. I didn’t think they would vote no with children’s lives on the line. I also think this is a lead up to the Covid Phase 3 trial results. They would be well aware on how it’s progressing and they need to move swiftly to ensure approvals are in place. To vote no for use with children would set the tone for the covid trial results. That’s my take on the matter. Not a long wait for the phase 3 results with the first interim analysis of remestemcel-L in ventilator-dependent COVID-19 patients due in early September.
The share price will be moved around a fair bit and manipulated as bigger parties attempt to cover but in my opinion the overall direction is up. I will be holding medium to longterm now to see how the covid-19 trial results fair. They desperately need a working treatment for covid.
MSB Trading 2020 - a new dawn, page-358
-
- There are more pages in this discussion • 12,713 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
-0.025(2.10%) |
Mkt cap ! $1.330B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $6.344M | 5.404M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8683 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 32999 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |